Upcoming Events
CE Courses
Applying Therapeutic Strategies to Improve the Quality of Life in Patients with Alzheimer’s Disease |
 This CME/CNE activity will review recent advances in the application of therapeutic strategies in the improvement of the quality of life in patients with Alzheimer’s disease (AD) as presented at the Florida State Neurology (FSN) 2018 meeting in Orlando, Florida… Webcast |
Utilizing Advanced Science to Improve the Quality of Life in Patients with Parkinson’s Disease |
 This CME/CNE activity will review advances in the utilization of innovative sciences in the improvement of the quality of life in patients with Parkinson’s disease (PD) as presented at the Florida State Neurology (FSN) 2018 meeting in Orlando, Florida… Webcast |
Understanding Lipoprotein(a)- Novel Therapeutics to Reduce Lp(a) Levels and Improve Cardiovascular Outcomes |
 This CME/CNE program will highlight content presented at the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany… Post Conference Review and Analysis |
Management of Patients with SMA: Standards of Care |
 In this module of a Five-Part Expert Interview Series, Dr. Robert Graham, along with Dr. Basil Darras, will discuss the standards of care guidelines and how to implement them while managing patients with SMA… Webcast |
Clinical Trial Data: New and Emerging Therapies for SMA |
 In this module of a Five-Part Expert Interview Series, Dr. Basil Darras, along with Dr. Robert Graham, will review clinical trial data including new and emerging therapies for spinal muscular atrophy… Webcast |
Common Standardized Scales for Measuring Motor Function in SMA |
 In this module of a Five-Part Expert Interview Series, Amy Pasternak, PT, DTP, PCS, along with Dr. Basil Darras, will discuss the standardized scales for measuring spinal muscular atrophy… Webcast |
Understanding the Characteristics of SMA and Diagnostic Criteria |
 In this module of a Five-Part Expert Interview Series, Dr. Basil Darras, along with Dr. Robert Graham, will analyze the characteristics of spinal muscular atrophy, as well as discussing the diagnostic criteria… Webcast |
Scientific Overview: The Pathology, Biology, and Molecular Genetics of SMA |
 In this module of a Five-Part Expert Interview Series, Dr. John Brandsema, along with Dr. Basil Darras, will review the pathology, biology and molecular genetics of spinal muscular atrophy (SMA)… Webcast |
Identifying Patients with Non-Tuberculous Mycobacterial Lung Disease for Optimal Treatment Decisions |
 This CME activity is derived from content presented at the 2018 Eastern Pulmonary Conference in Palm Springs, FL…. Webcast |
Identifying Financial and/or Treatment Access Barriers: Patient Perspectives |
 In this module of a Four-Part Expert Interview Series, Dr. James A. Underberg, along with Dr Christopher P. Cannon, course chair, will identify barriers to caring for dyslipidemia patients… Webcast |
Clinical Trial Analysis of PCSK9 Inhibitors: The Impact of Real-World Cardiovascular Outcomes |
 In this module of a Four-Part Expert Interview Series, Dr. Michael J. Blaha, along with Dr Christopher P. Cannon, course chair, will explore the role of PCSK9 inhibitors in the treatment of dyslipidemia patients and the impact of real-world cardiovascular outcomes… Webcast |
The Role of PCSK9 Inhibitors in Reducing CV Risk: Patient Selection Criteria and Treatment Initiation Tactics |
 In this module of a Four-Part Expert Interview Series, Dr. Robert P. Giugliano, along with Dr Christopher P. Cannon, course chair, will examine the role of PCSK9 inhibitors in reducing CV risk… Webcast |